FIELD: clinical pharmacology; ophthalmic pharmacology.
SUBSTANCE: group of inventions is intended for ophthalmic application of a stable composition containing povidone-iodine. An ophthalmic composition contains an aqueous phase, an oil phase and povidone-iodine (PVP-I) in concentration of 0.2–1.0 % (weight/weight). Said oil phase consists of triglycerides with average length of carbon chain and is less than 3 % of total weight of composition. Said composition can be formulated into a pharmaceutical preparation for ophthalmic therapeutic use. Also provided is a method of treating ophthalmic pathological conditions involving administering said composition.
EFFECT: use of group of inventions provides physical and chemical stability and preservation of high content of free molecular iodine, as well as good tolerance of patients in treating eye diseases.
13 cl, 1 dwg, 10 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
PYPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | 2007 |
|
RU2423101C2 |
COMPOSITION FOR TOPICAL USE | 2019 |
|
RU2806765C2 |
OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
MIXTURES CONTAINING (E)-3-BENZO[1,3]DIOXOL-5-YL-N,N-DIPHENYL-2-PROPENAMIDE | 2016 |
|
RU2731101C1 |
COSMETIC PRODUCTS BASED ON MOLECULAR IMPRINTED POLYMERS | 2007 |
|
RU2499607C2 |
LOCAL DISINFECTANT WHICH CONTAINS IODINE, HAVING LOW CONTENT OF SURFACTANT | 2012 |
|
RU2590825C2 |
PHARMACEUTICAL COMPOSITION OF TAXOIDS | 2011 |
|
RU2603833C2 |
APPLICATION OF DELTA-TOCOPHERYL-CARBOHYDRATE AS DEPIGMENTING AGENT | 2010 |
|
RU2542444C2 |
POLYAPHRON TOPICAL COMPOSITION WITH VITAMIN D AND CORTICOSTEROID | 2008 |
|
RU2466716C2 |
DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL-OR N, N-DIMETHYL-)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE | 2011 |
|
RU2589830C2 |
Authors
Dates
2021-01-21—Published
2017-02-17—Filed